Gilead Sciences Inc (GILD)
65.96
+1.38
(+2.14%)
USD |
NASDAQ |
May 10, 16:00
65.85
-0.11
(-0.17%)
After-Hours: 20:00
Gilead Sciences Price: 65.96 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 10, 2024 | 64.72 | 66.20 | 64.67 | 65.96 | 8.702M |
| May 09, 2024 | 65.18 | 65.22 | 64.52 | 64.58 | 6.049M |
| May 08, 2024 | 65.57 | 65.61 | 64.76 | 64.92 | 5.135M |
| May 07, 2024 | 65.43 | 66.14 | 65.16 | 65.46 | 7.318M |
| May 06, 2024 | 64.78 | 65.56 | 64.34 | 65.54 | 7.187M |
| May 03, 2024 | 65.51 | 65.53 | 64.33 | 64.78 | 7.823M |
| May 02, 2024 | 65.75 | 65.80 | 64.89 | 65.33 | 5.572M |
| May 01, 2024 | 65.32 | 65.89 | 64.97 | 65.51 | 7.233M |
| Apr 30, 2024 | 65.62 | 65.64 | 64.82 | 65.20 | 7.437M |
| Apr 29, 2024 | 65.30 | 66.91 | 65.20 | 65.94 | 7.839M |
| Apr 26, 2024 | 65.50 | 66.35 | 64.63 | 65.42 | 12.38M |
| Apr 25, 2024 | 67.47 | 67.90 | 65.09 | 65.27 | 15.17M |
| Apr 24, 2024 | 66.58 | 67.18 | 66.36 | 67.08 | 8.467M |
| Apr 23, 2024 | 67.09 | 67.68 | 67.00 | 67.03 | 5.240M |
| Apr 22, 2024 | 66.93 | 67.56 | 66.74 | 66.95 | 5.622M |
| Apr 19, 2024 | 66.25 | 66.83 | 66.16 | 66.76 | 10.66M |
| Apr 18, 2024 | 67.01 | 67.02 | 65.90 | 66.16 | 6.442M |
| Apr 17, 2024 | 67.35 | 67.55 | 66.89 | 66.93 | 5.288M |
| Apr 16, 2024 | 67.80 | 67.89 | 67.18 | 67.31 | 4.975M |
| Apr 15, 2024 | 68.27 | 68.46 | 67.70 | 67.75 | 7.718M |
| Apr 12, 2024 | 68.52 | 68.62 | 67.62 | 68.07 | 5.692M |
| Apr 11, 2024 | 68.46 | 69.02 | 68.30 | 68.65 | 6.072M |
| Apr 10, 2024 | 69.76 | 69.76 | 68.06 | 68.12 | 7.983M |
| Apr 09, 2024 | 69.16 | 69.95 | 69.11 | 69.94 | 5.928M |
| Apr 08, 2024 | 69.05 | 69.55 | 69.05 | 69.42 | 4.589M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
56.65
Minimum
Dec 30 2020
89.47
Maximum
Dec 08 2022
70.23
Average
68.09
Median
Jun 15 2021
Price Benchmarks
| CymaBay Therapeutics Inc (DELISTED) | 32.48 |
| Bristol-Myers Squibb Co | 44.94 |
| Merck & Co Inc | 130.06 |
| Pfizer Inc | 28.01 |
| Xilio Therapeutics Inc | 1.18 |
Price Related Metrics
| PE Ratio | 183.22 |
| PS Ratio | 3.014 |
| Price to Book Value | 4.685 |
| Price to Free Cash Flow | 10.47 |
| Earnings Yield | 0.55% |
| Market Cap | 82.18B |
| Operating PE Ratio | 12.86 |
| Normalized PE Ratio | 16.90 |